<DOC>
	<DOCNO>NCT00123266</DOCNO>
	<brief_summary>The purpose trial evaluate safety microplasmin well ability open block artery brain patient acute stroke give artery site blockage .</brief_summary>
	<brief_title>Intra-arterial Microplasmin Administration Patients With Acute Intracranial Vertebrobasilar Artery Occlusion</brief_title>
	<detailed_description>Patients angiographically document acute intracranial vertebrobasilar artery occlusion present within 24 hour neurological symptom onset enrol open-label trial . During study drug administration , angiograms repeat regular interval determine degree clot lysis .</detailed_description>
	<mesh_term>Plasminogen</mesh_term>
	<criteria>1 . Patients angiographically document vertebrobasilar artery occlusion 2 . Initiation study drug treatment within 24 hour onset neurological symptom 3 . Age 1875 ( inclusive ) . 1 . Patients coma &gt; 6 hrs duration complete loss brain stem reflex ( corneal reflex , gag reflex , VOR , pupil reflex ) measure last assessment sedation/intubation 2 . Rapidly improve neurologic sign time initiation study drug administration . 3 . Known contrast agentsensitivity 4 . Uncontrolled hypertension define systolic blood pressure &gt; 180 mm Hg diastolic blood pressure &gt; 100 mm Hg 3 separate occasion least 10 minute apart require continuous IV therapy . 5 . History stroke within previous 6 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>stroke</keyword>
	<keyword>vertebrobasilar</keyword>
	<keyword>basilar</keyword>
	<keyword>Acute vertebrobasilar artery occlusion</keyword>
</DOC>